https://www.businesswire.com/news/home/20201213005
Post# of 148184
(Total Views: 962)
Posted On: 12/14/2020 9:29:54 AM
https://www.businesswire.com/news/home/202012...kine-Storm
Another failed phase 3 s/c trial for Covid. This time Jakafi from Novartis. Looking more and more likely that leronlimab will be just one of a very small number of therapeutics able to take dying off the table.
Another failed phase 3 s/c trial for Covid. This time Jakafi from Novartis. Looking more and more likely that leronlimab will be just one of a very small number of therapeutics able to take dying off the table.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼